Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

Patient-reported complications from fiducial marker implantation for prostate image-guided radiotherapy.

Gill S, Li J, Thomas J, Bressel M, Thursky K, Styles C, Tai KH, Duchesne GM, Foroudi F.

Br J Radiol. 2012 Jul;85(1015):1011-7. doi: 10.1259/bjr/68127917. Epub 2012 Jan 17.

2.

Transperineal gold marker implantation for image-guided external beam radiotherapy of prostate cancer : A single institution, prospective study.

Jorgo K, Ágoston P, Major T, Takácsi-Nagy Z, Polgár C.

Strahlenther Onkol. 2017 Jun;193(6):452-458. doi: 10.1007/s00066-017-1104-2. Epub 2017 Feb 2.

PMID:
28154882
3.

[Use of gold radionuclide markers implanted into the prostate for image-guided radiotherapy in prostate cancer: side effects caused by the marker implantation].

Kliton J, Ágoston P, Szabó Z, Major T, Polgár C.

Magy Onkol. 2014 Sep;58(3):182-7. Epub 2014 Aug 2. Hungarian.

4.

Infections after fiducial marker implantation for prostate radiotherapy: are we underestimating the risks?

Loh J, Baker K, Sridharan S, Greer P, Wratten C, Capp A, Gallagher S, Martin J.

Radiat Oncol. 2015 Feb 13;10:38. doi: 10.1186/s13014-015-0347-2.

5.

Fiducial marker implantation in prostate radiation therapy: complication rates and technique.

Fawaz ZS, Yassa M, Nguyen DH, Vavassis P.

Cancer Radiother. 2014 Dec;18(8):736-9. doi: 10.1016/j.canrad.2014.07.160. Epub 2014 Oct 16.

PMID:
25451675
6.

Implantation of fiducial markers for image guidance in prostate radiotherapy: patient-reported toxicity.

Igdem S, Akpinar H, Alço G, Agaçayak F, Turkan S, Okkan S.

Br J Radiol. 2009 Nov;82(983):941-5. doi: 10.1259/bjr/14201041. Epub 2009 Jun 8.

PMID:
19505970
7.

Transperineal implantation of gold fiducial markers (gold seeds) for prostate image-guided radiation therapy: a feasible technique associated with a low risk of complications.

Saad A, Goldstein J, Lawrence YR, Weiss I, Saad R, Spieler B, Symon Z.

J Med Radiat Sci. 2015 Dec;62(4):261-6. doi: 10.1002/jmrs.122. Epub 2015 Jul 29.

8.

Single-center experience in prostate fiducial marker placement: technique and midterm follow-up.

Kably I, Bordegaray M, Shah K, Salsamendi J, Narayanan G.

J Vasc Interv Radiol. 2014 Jul;25(7):1125-1132.e1. doi: 10.1016/j.jvir.2014.03.017. Epub 2014 Apr 29.

PMID:
24788207
9.
10.

Prostatic fiducial markers implantation by transrectal ultrasound for adaptive image guided radiotherapy in localized cancer: 7-years experience.

Lacetera V, Cardinali M, Mantello G, Fenu F, Sbrollini G, Tombolini F, Conti A, Maggi S, Muzzonigro G, Galosi AB.

Arch Ital Urol Androl. 2014 Dec 30;86(4):349-52. doi: 10.4081/aiua.2014.4.349.

11.

[Intraprostatic fiducials in stereotactic radiotherapy for prostate cancer].

Cordoba A, Pasquier D, Nickers P, Lacornerie T, Lartigau É.

Cancer Radiother. 2016 Dec;20(8):815-819. doi: 10.1016/j.canrad.2016.07.097. Epub 2016 Oct 25. French.

PMID:
27793529
12.

Postprostatectomy ultrasound-guided transrectal implantation of gold markers for external beam radiotherapy. Technique and complications rate.

Langenhuijsen JF, Donker R, McColl GM, Kiemeney LA, Witjes JA, van Lin EN.

Strahlenther Onkol. 2013 Jun;189(6):476-81. doi: 10.1007/s00066-013-0323-4. Epub 2013 Apr 21.

PMID:
23604186
13.

Infections in oncology: urosepsis due to fluoroquinolone-resistant Escherichia coli after ultrasonographic-guided transrectal implantation of fiducial markers.

Buethe DD, Sexton WJ, Greene JN, Changcharoen B, Kue-A-Pai P.

Cancer Control. 2013 Jul;20(3):233-6. No abstract available.

PMID:
23811707
14.

Side-effects of post-treatment biopsies in prostate cancer patients treated with endocrine therapy alone or combined with radical radiotherapy in the Scandinavian Prostate Cancer Group-7 randomized trial.

Solberg A, Widmark A, Tasdemir I, Ahlgren G, Angelsen A.

Scand J Urol Nephrol. 2011 Sep;45(4):233-8. doi: 10.3109/00365599.2011.560577. Epub 2011 Mar 31.

PMID:
21452932
15.

Improved clinical outcomes with high-dose image guided radiotherapy compared with non-IGRT for the treatment of clinically localized prostate cancer.

Zelefsky MJ, Kollmeier M, Cox B, Fidaleo A, Sperling D, Pei X, Carver B, Coleman J, Lovelock M, Hunt M.

Int J Radiat Oncol Biol Phys. 2012 Sep 1;84(1):125-9. doi: 10.1016/j.ijrobp.2011.11.047. Epub 2012 Feb 11.

PMID:
22330997
16.

Ultrasound-guided transrectal implantation of gold markers for prostate localization during external beam radiotherapy: complication rate and risk factors.

Langenhuijsen JF, van Lin EN, Kiemeney LA, van der Vight LP, McColl GM, Visser AG, Witjes JA.

Int J Radiat Oncol Biol Phys. 2007 Nov 1;69(3):671-6. Epub 2007 May 23.

PMID:
17512133
17.

[Questionnaire based evaluation of prostate biopsy complication comparing different bioptic schemes].

Damiano R, Oliva A, Cantiello F, Esposito C, Perdonà S, De Sio M, Bitonti M, Sacco R, D'Armiento M.

Arch Ital Urol Androl. 2003 Mar;75(1):40-5. Italian.

PMID:
12741345
18.

Five-year follow-up using a prostate stent as fiducial in image-guided radiotherapy of prostate cancer.

Carl J, Sander L.

Acta Oncol. 2015 Jun;54(6):862-7. doi: 10.3109/0284186X.2014.987355. Epub 2014 Dec 24.

PMID:
25539443
19.

Treatment outcome of high-dose image-guided intensity-modulated radiotherapy using intra-prostate fiducial markers for localized prostate cancer at a single institute in Japan.

Takeda K, Takai Y, Narazaki K, Mitsuya M, Umezawa R, Kadoya N, Fujita Y, Sugawara T, Kubozono M, Shimizu E, Abe K, Shirata Y, Ishikawa Y, Yamamoto T, Kozumi M, Dobashi S, Matsushita H, Chida K, Ishidoya S, Arai Y, Jingu K, Yamada S.

Radiat Oncol. 2012 Jul 6;7:105. doi: 10.1186/1748-717X-7-105.

20.

Prospective assessment of urinary, gastrointestinal and sexual symptoms before, during and after image-guided volumetric modulated arc therapy for prostate cancer.

Sveistrup J, Widmark A, Fransson P, Iversen P, Munck Af Rosenschöld P, Engelholm SA, Petersen PM.

Scand J Urol. 2015 Feb;49(1):58-69. doi: 10.3109/21681805.2014.913258. Epub 2014 May 5.

PMID:
24793783

Supplemental Content

Support Center